8-K: Cibus Announces CEO Succession Plan: Rory Riggs Resigns, Peter Beetham Appointed Interim CEO

Cibus, Inc. announces that Rory Riggs has resigned as CEO and Peter Beetham has been appointed as Interim CEO as part of the company's succession planning strategy.

Summary

• Cibus, Inc. announced that Rory Riggs has resigned from his position as Chief Executive Officer, effective February 24, 2025.
• Riggs will remain a director and Chairman of the Board.
• Peter Beetham, the company's President and Chief Operating Officer, has been appointed as Interim Chief Executive Officer.
• The Board of Directors will initiate a search for a permanent CEO, considering both internal and external candidates.
• Dr. Beetham has served as President and COO since June 2023 and has been with Cibus Global since 2001, including serving as CEO and in other executive roles.
• The company issued a press release on February 28, 2025, regarding these leadership changes.

Sentiment

Score: 7

Explanation: The announcement is neutral to positive. The succession plan appears well-prepared, and the outgoing CEO remains on the board. However, the company's need for additional funding and other risks temper the overall sentiment.

Positives

• The company has a succession plan in place, ensuring a smooth transition in leadership.
• Peter Beetham, as a Cibus co-founder and leader, as well as a pioneer in agricultural gene editing, has been integral to getting Cibus to this point and is well poised to lead the company during this transition.
• Rory Riggs will remain Chairman of the Board, providing continued guidance and oversight.
• Cibus is at an important inflection point as it continues its transformation from an agricultural trait development company to a commercial trait company.

Risks

• The company acknowledges the need for additional near-term funding to finance its activities and challenges in obtaining additional capital on acceptable terms, or at all.
• The company faces challenges in respect of Cibus production of high-quality plants and seeds cost effectively on a large scale.
• The company faces changes in expected or existing competition, including competition from other traditional gene modification/plant breeding methodologies.
• The company faces challenges to Cibus intellectual property protection and unexpected costs associated with defending intellectual property rights.
• The company faces delays or disruptions in the Company's platform or trait product development efforts, particularly with respect to its non-Rice and nondisease projects in light of the Company's realigned strategic priorities.
• The company faces increased or unanticipated time and resources required for Cibus platform or trait product development efforts.
• The company faces challenges associated with Cibus ability to effectively license its productivity traits and sustainable ingredient products.
• The company faces the risk that farmers do not recognize the value in germplasm containing Cibus traits or that farmers and processors fail to work effectively with crops containing Cibus traits.
• The company faces dependence on distributions from Cibus Global, LLC to pay taxes and cover its corporate and overhead expenses.
• The company faces regulatory developments that disfavor or impose significant burdens on gene-editing processes or products.
• The company faces delays and uncertainties regarding regulatory developments in the European Union.
• The company faces commodity prices and other market risks facing the agricultural sector.
• The company faces technological developments that could render Cibus technologies obsolete.
• The company faces changes in macroeconomic and market conditions, including inflation, supply chain constraints, and rising interest rates.
• The company faces dislocations in the capital markets and challenges in accessing liquidity and the impact of such liquidity challenges on Cibus ability to execute on its business plan.

Future Outlook

Cibus is focused on its transformation from an agricultural trait development company to a commercial trait company, with a long-term focus on productivity traits for major global row crops.

Management Comments

• Mark Finn, lead independent director of the Board, acknowledged Rory's unwavering dedication to Cibus and his instrumental role in building the company.
• Rory Riggs stated he is looking forward to continuing his work on the Board and is fully confident the Company will execute a seamless transition.
• Rory Riggs stated that one of his key objectives as Chief Executive Officer was to demonstrate the potential of our RTDS technologies and our Trait Machine process and that they've met that objective.
• Rory Riggs stated that he believes that now is the right time to formally activate our succession planning and begin the transition to Cibus next leader as its commercial transformation accelerates.

Industry Context

The announcement reflects the ongoing evolution of agricultural technology companies and the increasing focus on commercializing gene-edited traits. Cibus is positioning itself as a technology provider to seed companies, rather than a direct competitor.

Comparison to Industry Standards

• Cibus's strategy of licensing traits to seed companies is similar to that of other agricultural technology companies like Benson Hill and Pairwise, which focus on developing and commercializing gene-edited crops.
• The company's focus on productivity traits for major row crops aligns with industry trends towards improving crop yields and sustainability.
• Cibus's RTDS technology is positioned as a faster and more cost-effective alternative to traditional breeding methods, similar to other gene-editing platforms like CRISPR.

Management Changes

Stakeholder Impact

• Shareholders may experience short-term uncertainty due to the leadership transition, but the company's long-term strategy remains unchanged.
• Employees may experience some disruption during the transition period, but the company's leadership team is expected to ensure strong execution of commercial priorities.
• Seed companies and farmers may benefit from Cibus's continued development of productivity traits.

Next Steps

• The Board of Directors will initiate a search for the Company's next CEO.
• Peter Beetham will serve as Interim CEO during the search process.
• Cibus will continue to focus on its commercial priorities and the development of its RTDS technology.

Key Dates